Failure of atovaquone-proguanil malaria chemoprophylaxis in a traveler to Ghana

被引：11
|
作者：
Boggild, Andrea K. [1 ,2 ,3 ]
Lau, Rachel [3 ]
Reynaud, Denis [4 ]
Kain, Kevin C. [1 ,2 ,5 ]
Gerson, Marvin [6 ]
机构：
[1] Univ Hlth Network, Toronto Gen Hosp, Div Infect Dis, Trop Dis Unit, Toronto, ON, Canada
[2] Univ Toronto, Dept Med, Toronto, ON, Canada
[3] Publ Hlth Ontario, Publ Hlth Ontario Labs, Toronto, ON, Canada
[4] Hosp Sick Children, Ctr Study Complex Childhood Dis, Toronto, ON M5G 1X8, Canada
[5] Univ Toronto, Sandra Rotman Ctr Global Hlth, Sandra A Rotman Labs, Toronto, ON M5S 1A1, Canada
[6] Humber River Hosp, N York, ON, Canada
来源：
TRAVEL MEDICINE AND INFECTIOUS DISEASE | 2015年 / 13卷 / 01期
关键词：
Drug resistance; Malabsorption; Malaria; Malarone; Plasmodium falciparum; TIME QUANTITATIVE PCR; GENE COPY NUMBER; PLASMODIUM-FALCIPARUM; GEOSENTINEL SURVEILLANCE; RETURNED TRAVELERS; TREATMENT POLICY; RESISTANCE; CHLOROQUINE; CHILDREN; DISEASES;
D O I：
10.1016/j.tmaid.2014.12.010
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
Clinical failure of Malarone (TM) chemoprophylaxis is extremely rare. We report a case of Plasmodium falciparum malaria in a returned traveler to Ghana who fully adhered to atovaquone-proguanil (Malarone (TM)) chemoprophylaxis daily dosing, yet took the pills on an empty stomach. Screening of the P. falciparum isolate revealed triple codon mutation of Dhfr at positions 51, 59, and 108. Plasma drug levels of both atovaquone and proguanil revealed sub-therapeutic concentrations. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码：89 / 93
页数：5
相关论文
共 50 条
  • [21] Late clinical failure associated with cytochrome b codon 268 mutation during treatment of falciparum malaria with atovaquone-proguanil in traveller returning from Congo
    Massamba, Laurencie
    Madamet, Marylin
    Benoit, Nicolas
    Chevalier, Alicia
    Fonta, Isabelle
    Mondain, Veronique
    Jeandel, Pierre-Yves
    Amalvict, Remy
    Delaunay, Pascal
    Mosnier, Joel
    Marty, Pierre
    Pomares, Christelle
    Pradines, Bruno
    MALARIA JOURNAL, 2020, 19 (01)
  • [22] Questionnaire-based analysis of atovaquone-proguanil compared with mefloquine in the chemoprophylaxis of malaria in non-immune Japanese travelers
    Kato, Tetsuro
    Okuda, Joji
    Ide, Daisuke
    Amano, Katsushi
    Takei, Yutaka
    Yamaguchi, Yuko
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2013, 19 (01) : 20 - 23
  • [23] Atovaquone-Proguanil in Combination With Artesunate to Treat Multidrug-Resistant P. falciparum Malaria in Cambodia: An Open-Label Randomized Trial
    Wojnarski, Mariusz
    Lon, Chanthap
    Vanachayangkul, Pattaraporn
    Gosi, Panita
    Sok, Somethy
    Rachmat, Agus
    Harrison, Dustin
    Berjohn, Catherine M.
    Spring, Michele
    Chaoratanakawee, Suwanna
    Ittiverakul, Mali
    Buathong, Nillawan
    Chann, Soklyda
    Wongarunkochakorn, Saowaluk
    Waltmann, Andreea
    Kuntawunginn, Worachet
    Fukuda, Mark M.
    Burkly, Hana
    Heang, Vireak
    Thay Keang Heng
    Kong, Nareth
    Boonchan, Threechada
    Chum, Bolin
    Smith, Philip
    Vaughn, Andrew
    Prom, Satharath
    Lin, Jessica
    Lek, Dysoley
    Saunders, David
    OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (09):
  • [24] Safety of atovaquone-proguanil during pregnancy
    Mayer, Romana C.
    Tan, Kathrine R.
    Gutman, Julie R.
    JOURNAL OF TRAVEL MEDICINE, 2019, 26 (04)
  • [25] Travellers' adherence to atovaquone/proguanil malaria chemoprophylaxis after return from endemic areas
    Schnyder, Jenny Lea
    Birkhoff, David Cornelis
    Jarings, Myrthe Celine
    Hermans, Sabine Margot
    Grobusch, Martin Peter
    de Jong, Hanna Katrien
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2025, 64
  • [26] Causal prophylactic efficacy of atovaquone-proguanil (Malarone™) in a human challenge model
    Berman, JD
    Nielsen, R
    Chulay, JD
    Dowler, M
    Kain, KC
    Kester, KE
    Williams, J
    Whelen, AC
    Shmuklarsky, MJ
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2001, 95 (04) : 429 - 432
  • [27] A Longitudinal Trial Comparing Chloroquine as Monotherapy or in Combination with Artesunate, Azithromycin or Atovaquone-Proguanil to Treat Malaria
    Laufer, Miriam K.
    Thesing, Phillip C.
    Dzinjalamala, Fraction K.
    Nyirenda, Osward M.
    Masonga, Rhoda
    Laurens, Matthew B.
    Stokes-Riner, Abbie
    Taylor, Terrie E.
    Plowe, Christopher V.
    PLOS ONE, 2012, 7 (08):
  • [28] Assessment of Adherence to Atovaquone-Proguanil Prophylaxis in Travelers
    DePetrillo, John C.
    Singer, Carol
    Bergagnini, Isabella A.
    Kolakowski, Patricia
    Edwards, Barbara
    Smith, Miriam A.
    JOURNAL OF TRAVEL MEDICINE, 2010, 17 (04) : 217 - 220
  • [29] Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations
    Musset, Lise
    Bouchaud, Olivier
    Matheron, Sophie
    Massias, Laurent
    Le Bras, Jacques
    MICROBES AND INFECTION, 2006, 8 (11) : 2599 - 2604
  • [30] The diminishing returns of atovaquone-proguanil for elimination of Plasmodium falciparum malaria: modelling mass drug administration and treatment
    Richard J Maude
    Chea Nguon
    Arjen M Dondorp
    Lisa J White
    Nicholas J White
    Malaria Journal, 13
12345